## **Core Concept**
Paroxysmal supraventricular tachycardia (PSVT) is a condition characterized by episodes of rapid heart rate originating above the ventricles. The management of PSVT often involves the use of medications that can help terminate the acute episode or prevent its recurrence. The drugs used typically work by either blocking AV nodal conduction or by prolonging the AV nodal refractory period.
## **Why the Correct Answer is Right**
The correct answer, Adenosine (or **Adenosine**), is the drug of choice for the acute management of PSVT. Adenosine works by transiently blocking AV nodal conduction, which effectively terminates the re-entrant circuit that sustains the tachycardia. It has a very short half-life, which makes it safe for use with minimal side effects, although transient bradycardia and hypotension can occur.
## **Why Each Wrong Option is Incorrect**
- **Option A: Verapamil** - While verapamil, a calcium channel blocker, can be used to manage PSVT by reducing AV nodal conduction, it is not the first-line treatment for acute episodes due to its slower onset of action compared to adenosine and potential for causing hypotension.
- **Option B: Propranolol** - Propranolol, a beta-blocker, can be used in the management of certain types of tachycardias but is not the drug of choice for acute termination of PSVT.
- **Option D: Digoxin** - Digoxin has a slower onset of action and is less effective for the acute termination of PSVT, making it less suitable as a first-line treatment for acute episodes.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that adenosine has a very short half-life and its administration should be followed by a rapid saline flush to ensure it reaches the heart quickly. Additionally, because adenosine can cause transient but significant bradycardia, patients should be monitored closely during its administration.
## **Correct Answer:** . Adenosine
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.